I
n the United States, New York orthohantavirus (NYV) is carried by the white-footed mouse (Peromyscus leucopus). During 1993-1995, human cases of NYV infection were reported in persons who visited or resided on Long Island, New York, USA (1) . Since that time, no other cases have been reported on Long Island. We report an NYV infection with unusual clinical manifestations.
A 52-year-old woman from the east end of Long Island came to an emergency department in May 2017 because of fevers, headaches, myalgias, vomiting, somnolence, and lethargy for 3 days. She had a history of tick exposure and had recently cleaned her basement, where she reported observing mice droppings.
The patient had a core temperature of 102°F, a heart rate of 108 beats/min, a respiration rate of 20 breaths/ min, and a blood pressure of 94/56 mm Hg. On day 4 postonset, her condition rapidly deteriorated. A second chest radiograph showed developing pulmonary congestion, and she required intubation and mechanical ventilation. She also had severe thrombocytopenia (18,000/ platelets mm 3 ), acute kidney injury, proteinuria and microhematuria (peak creatinine 2.3 mg/dL, urinary protein 30 mg/dL, 50 erythrocytes/high-powered field), worsening transaminitis (aspartate aminotransferase 329 U/L, alanine aminotransferase 258 U/L), and an increased lactate dehydrogenase (769 U/L). A computed tomography (CT) scan of the lungs showed bilateral pleural effusions (day 6 postonset). Because a CT scan of the head showed cerebral edema, the patient was transferred to a tertiary care hospital (day 7 postonset).
Serologic test results were negative for Powassan virus, Ehrlichia spp., Anaplasma spp., Lyme disease, and Rocky Mountain spotted fever. Results of a hantavirus IgM and IgG ELISA (recognizing the nucleocapsid protein common to all hantaviruses) were positive (Associated Regional and University Pathologists Laboratories, https:// www.aruplab.com). An acute hantavirus infection was confirmed by the Centers for Disease Control and Prevention (Atlanta, GA, USA) by ELISA and identified antibodies that cross-reacted with Sin Nombre virus antigens (serum titers: IgM 1:6,400 and IgG 1:400). Orthohantavirus RNA was also detected by using reverse transcription PCR specific for the large RNA segment (2) .
Although the patient's condition improved on day 14 postonset, she had 3 episodes of witnessed tonic-clonic seizures. A CT scan of the head showed an acute intraparenchymal hemorrhage (platelet count range 37,000/µL-57,000/ µL) in the left basal ganglia with intraventricular extension into the left lateral and third ventricles and hydrocephalus that required placement of an emergent external ventricular drain. Blood and cerebrospinal fluid (CSF) collected at day 15 postonset had undetectable levels of virus RNA but IgM (serum 1:6,400, CSF 1:20) and IgG (serum 1:6,400, CSF 1:20) antibody titers had increased. She was discharged on day 26 postonset and given anticonvulsant therapy. One year later, the patient was asymptomatic.
We sequenced hantavirus RNA isolated from the initial blood specimen by using Sanger and unbiased nextgeneration sequencing (Figure) . Phylogenetic analysis of a partial genome inferred that the virus had a most recent common ancestor with an NYV collected in 1994 from a white-footed mouse from Shelter Island, NY (3). Given the inferred evolutionary relationship, our data are consistent with disease transmission likely occurring after contact with excreta from a local rodent. It is unclear if NYV (formerly classified as a distinct species) might have caused the neurologic complications (hydrocephalus and intracranial bleeding) for this case. Neurologic signs and symptoms did not develop for previous cases of infection with NYV (1).
Hantavirus pulmonary syndrome is a severe respiratory illness caused by infection with New World hantaviruses (4). During 1993-2015, a total of 688 cases of hantavirus pulmonary syndrome were reported in the United States (casefatality rate 36%) (5). We report an orthohantavirus infection that progressed to respiratory failure and renal impairment (9), which raises the question whether intracranial bleeding for this case-patient was associated with endothelial damage directly from the virus infection.
In conclusion, we report an orthohantavirus infection in New York that caused intracranial bleeding and hydrocephalus that required an emergent surgical intervention. Because orthohantaviruses are endemic to North America and several strains/species have not been fully characterized, it is essential that clinicians recognize and be aware of other clinical manifestations of these infections (e.g., kidney injury), which are often indicators of subsequent complications.
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